AJMC® in the Press, January 23, 2026

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Health outcomes and inpatient costs improved for veterans when the federal government invested in preventing homelessness.

January 20th 2026

How ED Policies Can Better Protect Survivors of Violence: A Q&A With Prashasti Bhatnagar, Esq, MPH

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

A new study highlights how formalized, trauma-informed policies in emergency departments could better protect survivors of violence, said Prashasti Bhatnagar.

Managed Care Cast News Roundup: January 13, 2026

A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines trauma-informed, patient-centered policy solutions.

January 13th 2026

Semaglutide Shows Promise for Steatohepatitis Resolution in MASH

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Listen

semaglutide stethoscope | Image credit: Nati - stock.adobe.com

Ocular Symptoms, Malignancy Common in Double Seronegative MG

Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures.

Eyes | Image credit: Serg Zastavkin - stock.adobe.com

Federal Prevention Solutions to Homelessness Improved Health Outcomes in VA Patients

A review of case studies found that patients with double seronegative myasthenia gravis (MG) had similarities in the ways their condition presented.

Related Content

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Health outcomes and inpatient costs improved for veterans when the federal government invested in preventing homelessness.

January 20th 2026

How ED Policies Can Better Protect Survivors of Violence: A Q&A With Prashasti Bhatnagar, Esq, MPH

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Managed Care Cast News Roundup: January 13, 2026

A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines trauma-informed, patient-centered policy solutions.

January 13th 2026

Semaglutide Shows Promise for Steatohepatitis Resolution in MASH

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Listen

Ocular Symptoms, Malignancy Common in Double Seronegative MG

Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures.